Ontario Shores Centre for Mental Health Sciences
15
4
4
8
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
13.3%
2 terminated/withdrawn out of 15 trials
80.0%
-6.5% vs industry average
7%
1 trials in Phase 3/4
13%
1 of 8 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (15)
i-CBT and IV Ketamine for Suicidality in Treatment-Resistant Depression: A Randomized, Midazolam-Controlled Clinical Trial
Role: collaborator
Outcomes From Remediation and Behavioural Intervention Techniques
Role: collaborator
EEG Outcomes From Cognitive Behavioural Therapy for Psychosis
Role: collaborator
Virtual Cognitive Behavioural Therapy for Psychosis
Role: collaborator
Predictors of Relapse in Major Depressive Disorder
Role: collaborator
Efficacy of Convulsive Therapies During Continuation
Role: collaborator
Efficacy of Convulsive Therapies for Bipolar Depression
Role: collaborator
tDCS and Executive Function Training for Schizophrenia
Role: collaborator
Accelerated Bilateral Sequential Theta Burst Stimulation in Older Adults With Treatment-resistant Depression
Role: lead
Ketamine Versus Electroconvulsive Therapy in Depression
Role: collaborator
Mindbeacon Therapist Assisted Internet Delivered CBT for Depression
Role: lead
A Smartphone Intervention With Telemedicine Support for Management of Post-traumatic Stress Disorder: A Randomized Trial
Role: lead
Accelerated Intermittent Theta Burst Stimulation for Depressed Patients During the Covid-19 Pandemic
Role: lead
Safety and Efficacy of Electroconvulsive Therapy (ECT) for Behavioural and Psychological Symptoms of Dementia (BPSD)
Role: collaborator
Evaluate the Value of Telehomecare for Mental Health
Role: collaborator
All 15 trials loaded